Capstan Therapeutics logo

Capstan Therapeutics

Acquired

Facts

Sectors
Biotechnology, Biopharma, Cell therapy
Founded
2021
Status
Acquired
Stage
Acquired

Is this your organization? Claim it

Shield AI Leads San Diego VC in 2025 with $240M Series F at $5B Valuation; Crystalys Raises $205M Series A

San Diego startups raised more than $100 million across 11 local companies in 2025, led by Shield AI’s $240M Series F at a $5B valuation and Crystalys Therapeutics’ $205M Series A; overall deal count fell 6% year-over-year to 152. Three San Diego companies — Aardvark Therapeutics, Carlsmed and Aptera Motors — went public, and the city ranked seventh nationally for VC funding through Series C.